# Study Evaluating the Efficacy and Safety of Artesunate

> **NCT06853184** · PHASE2 · RECRUITING · sponsor: **Amivas Inc.** · enrollment: 90 (estimated)

## Conditions studied

- CMV Infection

## Interventions

- **DRUG:** Artesunate
- **DRUG:** Ganciclovir (GCV)

## Key facts

- **NCT ID:** NCT06853184
- **Lead sponsor:** Amivas Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2028-05-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06853184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06853184, "Study Evaluating the Efficacy and Safety of Artesunate". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06853184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*